Glazer Capital LLC’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Glazer Capital LLC’s Portfolio MRTX Stock Details MRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-8,297	Closed	-$487K	–	166
2023 Q4	$487K	Buy	+8,297	New	+$466K	0.05%	117

Other funds holding MRTX

Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Glazer Capital LLC's MRTX Position: Q1 2024 in Review

Glazer Capital LLC sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q1 2024, closing a stake of 8,297 shares — an estimated $487K sold.

Glazer Capital LLC first reported a position in MRTX in Q4 2023 and held it in 1 quarter. The position peaked at $487K in Q4 2023. 2 funds tracked by Wall St. Rank hold MRTX as of Q1 2024.

Glazer Capital LLC reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Glazer Capital LLC sold 8,297 Mirati Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $487K.
Glazer Capital LLC first reported a position in Mirati Therapeutics, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
Glazer Capital LLC's Mirati Therapeutics, Inc. Common Stock position peaked at $487K in Q4 2023.
2 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Glazer Capital LLC's 13F filing for Q1 2024, filed 15 May 2024.